NCT07635602

Brief Summary

Collect raw data from CS BP Pillow System and Arterial line (A-line) in volunteers. The data collected in the study will be used for development of the CS BP algorithm.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
40

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Feb 2026

Shorter than P25 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

February 10, 2026

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

April 8, 2026

Completed
22 days until next milestone

Primary Completion

Last participant's last visit for primary outcome

April 30, 2026

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

April 30, 2026

Completed
1 month until next milestone

First Posted

Study publicly available on registry

June 9, 2026

Completed
Last Updated

June 9, 2026

Status Verified

June 1, 2026

Enrollment Period

3 months

First QC Date

April 8, 2026

Last Update Submit

June 3, 2026

Conditions

Keywords

blood pressure

Outcome Measures

Primary Outcomes (1)

  • Number of subjects with complete protocol-defined multi-modal physiological signal acquisition

    The primary outcome measure is the number of subjects with complete protocol-defined multi-modal physiological signal acquisition Multi-modal physiological signal acquisition includes simultaneous recording of: (i) photoplethysmography (PPG); ii) single lead electrocardiography (ECG); iii) tonometry signals from the investigational BP Pillow System ; (iv) continuous invasive arterial blood pressure signals.

    day 1, 1 hour

Study Arms (1)

CS BP Pillow System

EXPERIMENTAL

Data collected from the CS BP Pillow System will be compared to data collected from Arterial Line

Device: CS BP Pillow System

Interventions

Device: CS Pillow System \- The system estimates BP using a combination of ECG and tonometry signals. The system is comprised of a tonometry-based sensor which is embedded in a biocompatible "pillow" for improved sensitivity and comfort. The Pillow is placed over the pulsatile area of the radial artery using a wristband. Data collected using the CS Pillow System will be compared to data collected using Arterial Line.

Also known as: Arterial Line
CS BP Pillow System

Eligibility Criteria

Age40 Years - 80 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • years old.
  • Ability and willingness to sign and understand an informed consent form.
  • The participant has a palpable radial pulse in both wrists.
  • The participant is willing and able to be fitted with the investigational device, A-line, and reference cuff, and is willing and able to undergo all study procedures, including 1 hour of recording with the investigational device and A-line.

You may not qualify if:

  • Participant who are currently enrolled in another clinical investigation in which the intervention might compromise the safety of the participant or interfere with the data collected.
  • Participant whose body habitus precludes them from wearing the investigational device on their wrist.
  • Female participants who self-reported as pregnant based on a urine pregnancy test, or who are self-reported as trying to get pregnant or who are breastfeeding.
  • Participant whose BMI is greater than 35.
  • Participant with a documented medical history of cardiac arrhythmia.
  • Participant with diagnosed diabetes mellitus.
  • Participant with implanted cardiac defibrillators or pacemakers, Ventricular Assist Device (VAD) or other mechanical circulatory support devices, whether intracorporal or extracorporeal.
  • Participant with stage 4 or stage 5 end-stage renal disease, or participants with arteriovenous shunts.
  • Participant with pheochromocytoma or primary hyperaldosteronism.
  • Participant with diagnosed heart failure with New York Heart Association (NYHA) class III/IV, or participants with a history of stroke.
  • Participant with a known clotting disorders or currently taking a prescription anticoagulants (daily aspirin use is permitted).
  • Participant with an infection requiring antibiotics.
  • Participant with peripheral artery disease
  • Participants with compromised circulation, including Raynaud's syndrome.
  • Participant has a fracture, severe trauma, or anatomical deformity involving the wrist intended for placement of the investigational product, which could interfere with proper fitting or function of the device.
  • +4 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Element Boulder Avista Adventist Hospital Plaza

Louisville, Colorado, 80027, United States

Location

MeSH Terms

Interventions

Vascular Access Devices

Intervention Hierarchy (Ancestors)

CathetersEquipment and Supplies

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
OTHER
Intervention Model
SINGLE GROUP
Sponsor Type
INDUSTRY
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 8, 2026

First Posted

June 9, 2026

Study Start

February 10, 2026

Primary Completion

April 30, 2026

Study Completion

April 30, 2026

Last Updated

June 9, 2026

Record last verified: 2026-06

Locations